What is William Blair’s Estimate for Enovix Q1 Earnings?

Enovix Co. (NASDAQ:ENVXFree Report) – Research analysts at William Blair issued their Q1 2026 earnings per share estimates for Enovix in a research note issued on Thursday, February 20th. William Blair analyst J. Dorsheimer anticipates that the company will post earnings per share of ($0.29) for the quarter. The consensus estimate for Enovix’s current full-year earnings is ($1.01) per share. William Blair also issued estimates for Enovix’s Q2 2026 earnings at ($0.29) EPS, Q3 2026 earnings at ($0.29) EPS and Q4 2026 earnings at ($0.28) EPS.

Enovix (NASDAQ:ENVXGet Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.01. The company had revenue of $9.72 million during the quarter, compared to analyst estimates of $8.77 million. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%.

A number of other brokerages have also recently commented on ENVX. Craig Hallum reduced their target price on Enovix from $20.00 to $18.00 and set a “buy” rating for the company in a report on Thursday. Janney Montgomery Scott cut Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a research report on Thursday, October 31st. Benchmark reaffirmed a “buy” rating and set a $25.00 target price on shares of Enovix in a research note on Wednesday, October 30th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $30.00 target price on shares of Enovix in a report on Thursday. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $20.30.

Get Our Latest Research Report on Enovix

Enovix Stock Down 6.6 %

ENVX stock opened at $10.72 on Monday. Enovix has a 52 week low of $5.70 and a 52 week high of $18.68. The company has a quick ratio of 3.61, a current ratio of 3.77 and a debt-to-equity ratio of 0.99. The firm has a 50-day simple moving average of $11.15 and a 200-day simple moving average of $10.29. The stock has a market capitalization of $1.91 billion, a P/E ratio of -7.39 and a beta of 1.87.

Institutional Trading of Enovix

Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Enovix by 15.1% during the 4th quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company’s stock worth $171,458,000 after purchasing an additional 2,063,631 shares during the last quarter. Electron Capital Partners LLC boosted its position in shares of Enovix by 0.5% during the 4th quarter. Electron Capital Partners LLC now owns 5,658,734 shares of the company’s stock worth $61,510,000 after acquiring an additional 29,109 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Enovix by 6.6% in the 4th quarter. Geode Capital Management LLC now owns 3,818,827 shares of the company’s stock valued at $41,520,000 after acquiring an additional 235,142 shares during the last quarter. Royal Bank of Canada raised its position in shares of Enovix by 1.5% during the 4th quarter. Royal Bank of Canada now owns 1,933,073 shares of the company’s stock worth $21,012,000 after acquiring an additional 28,591 shares in the last quarter. Finally, Fred Alger Management LLC lifted its stake in Enovix by 212.4% during the fourth quarter. Fred Alger Management LLC now owns 1,838,914 shares of the company’s stock worth $19,989,000 after purchasing an additional 1,250,300 shares during the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.

Insider Activity at Enovix

In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total value of $729,750.00. Following the sale, the director now owns 99,497 shares of the company’s stock, valued at $968,105.81. This trade represents a 42.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 15.70% of the stock is currently owned by company insiders.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Further Reading

Earnings History and Estimates for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.